Figure 1From: Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia Expression level of BCR-ABL major fusion gene at various time during therapy measured by real-time quantitative PCR using ABL gene amplification as a control. Back to article page